Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease (Q43719489)

26 November 2017

Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease (English)

1 reference

polycystic ovary syndrome

26 November 2017

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

1 reference

Sabuncu T

1

1 reference

26 November 2017

Vural H

series ordinal

2

1 reference

26 November 2017

Harma M

series ordinal

3

1 reference

26 November 2017

Harma M

series ordinal

4

1 reference

26 November 2017

1 July 2001

1 reference

26 November 2017

Clinical Biochemistry

1 reference

26 November 2017

34

1 reference

26 November 2017

407-413

1 reference

26 November 2017

5

1 reference

Polycystic ovary syndrome

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Obesity, lipids, cardiovascular risk, and androgen excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Coronary heart disease risk factors in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Clinical signs of androgen excess as risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Oxygen-derived free radicals in postischemic tissue injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

The oxygen free radical system: potential mediator of myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Role of oxygen free radicals in ischemic and reperfused myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Lipid peroxidation and protective enzymes during myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Free radical pathology in chronic arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Antioxidant therapy--a new therapeutic option for reducing mortality from coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Free-radical oxidation and antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Oxidative stress and antioxidative status of plasma and erythrocytes in patients with vivax malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Reduction of lipid peroxidation in different rat brain areas after cabergoline treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Polycystic ovarian disease: US features in 104 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: stronger associations in lean versus obese subjects. Atherosclerosis Risk in Communities Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Antioxidant enzyme alterations in experimental and clinical diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Racial differences in the relation between blood pressure and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Role of oxidized low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Normal serum uric acid concentrations in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Serum antioxidant status in streptozotocin-induced diabetic rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

Superoxide dismutase, catalase and glutathione peroxidase activities in human blood: influence of sex, age and cigarette smoking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900245-4

10.1016/S0009-9120(01)00245-4

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference